Knocking out PYCR2 inhibits the proliferation, migration, and invasion of colon cancer [10,11] and also influences the development of melanoma, bladder cancer, nasopharyngeal carcinoma, gastric cancer, and other tumors [12,13,14,15]. This evidence concerns the gene PYCR2 and urinary bladder cancer.